EcoDrugPlus

Solute Carrier Family 6 Member 4

Ensembl ID : ENSOPRG00000007894
Gene Symbol: SLC6A4
1 Cross references
203 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSOPRG00000013803
Gene Symbol: SLC6A9
1 Cross references
208 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSOPRG00000007442
Gene Symbol: SSTR2
1 Cross references
263 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSOPRG00000014238
Gene Symbol: SSTR3
1 Cross references
249 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSOPRG00000017290
Gene Symbol: SSTR5
1 Cross references
256 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSOPRG00000002119
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSOPRG00000003820
Gene Symbol: SYK
1 Cross references
200 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSOPRG00000015372
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSOPRG00000016504
Gene Symbol: SNCA
1 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSOPRG00000000051
Gene Symbol: TACR1
1 Cross references
267 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSOPRG00000001798
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSOPRG00000009936
Gene Symbol: TBXAS1
1 Cross references
219 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).